Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure
暂无分享,去创建一个
L. Trizio | M. Tutino | S. Dragonieri | F. Longobardi | M. Tutino | M. Musti | G. Gennaro | L. Trizio | G. Stallone | G. Gennaro | S. Dragonieri | F. Longobardi | M. Musti | G. Stallone | Silvano Dragonieri | Francesco Longobardi | Maria Tutino
[1] Teuvo Kohonen,et al. Self-organization and associative memory: 3rd edition , 1989 .
[2] M. Phillips. Method for the collection and assay of volatile organic compounds in breath. , 1997, Analytical biochemistry.
[3] M. Friedrich,et al. Scientists seek to sniff out diseases: electronic "noses" may someday be diagnostic tools. , 2009, JAMA.
[4] H. Pass,et al. Current concepts in malignant pleural mesothelioma , 2008, Expert review of anticancer therapy.
[5] Peter J Sterk,et al. An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.
[6] B. Robinson,et al. Advances in malignant mesothelioma. , 2005, The New England journal of medicine.
[7] J. Zahn,et al. Bias of Tedlar bags in the measurement of agricultural odorants. , 2006, Journal of environmental quality.
[8] D. Rice,et al. Diagnosis, Staging, and Surgical Treatment of Malignant Pleural Mesothelioma , 2008, Current treatment options in oncology.
[9] Jure Zupan,et al. Kohonen and counterpropagation artificial neural networks in analytical chemistry , 1997 .
[10] L. Freitag,et al. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study , 2009, Thorax.
[11] L. Greillier,et al. Mesothelioma and Asbestos-Related Pleural Diseases , 2008, Respiration.
[12] P. Gross. Biologic activity of epsilon-caprolactam. , 1984, Critical reviews in toxicology.
[13] P. Gross. Biologic Activity of ε-Caprolactam , 1984 .
[14] P. Baas,et al. Biomarkers for Malignant Pleural Mesothelioma , 2008, Molecular Diagnosis & Therapy.
[15] P. Španěl,et al. The challenge of breath analysis for clinical diagnosis and therapeutic monitoring. , 2007, The Analyst.
[16] Simona M Cristescu,et al. The suitability of Tedlar bags for breath sampling in medical diagnostic research , 2007, Physiological measurement.
[17] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[18] Johann Gasteiger,et al. Neural networks in chemistry and drug design , 1999 .
[19] H. J. O’neill,et al. Volatile organic compounds in exhaled air from patients with lung cancer. , 1985, Clinical chemistry.
[20] R. Fall,et al. Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. , 2001, Journal of applied physiology.
[21] G. Giaccone,et al. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M. Tutino,et al. Monitoring of volatile organic compounds in non-residential indoor environments. , 2008, Indoor air.
[23] G. Rooth,et al. Acetone in alveolar air, and the control of diabetes. , 1966, Lancet.
[24] S. Wacholder,et al. Environment And Genetics in Lung cancer Etiology (EAGLE) study: An integrative population-based case-control study of lung cancer , 2008, BMC public health.
[25] J D Pleil,et al. Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds. , 1997, Clinical chemistry.
[26] M. Phillips,et al. Volatile organic compounds in the breath of patients with schizophrenia. , 1995, Journal of clinical pathology.
[27] A. B. Robinson,et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[28] F. G. Río,et al. New screening method for lung cancer by detecting volatile organic compounds in breath , 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[29] Dall Jl,et al. MORE ACID/BASE DISTURBANCES. , 1963 .